These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19669848)

  • 21. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of fondaparinux versus enoxaparin after TKA in Japanese patients.
    Hosaka K; Saito S; Ishii T; Sumino T; Ryu K; Suzuki G; Suzuki T; Tokuhashi Y
    Orthopedics; 2013 Apr; 36(4):e428-33. PubMed ID: 23590781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of anticoagulation for thromboembolism in early postoperative total joint arthroplasty.
    Bloomfield MR; Patterson RW; Froimson MI
    Am J Orthop (Belle Mead NJ); 2011 Aug; 40(8):E148-51. PubMed ID: 22016874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
    Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
    N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.
    King DA; Pow RE; Dickison DM; Vale PR
    Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty.
    Gombár C; Horvath G; Gálity H; Sisák K; Tóth K
    Arch Orthop Trauma Surg; 2014 Apr; 134(4):449-57. PubMed ID: 24488447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Portman RJ
    N Engl J Med; 2009 Aug; 361(6):594-604. PubMed ID: 19657123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
    Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
    Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
    JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
    Runner RP; Shau DN; Staley CA; Roberson JR
    J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
    Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
    Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.
    Haighton M; Kempen DH; Wolterbeek N; Marting LN; van Dijk M; Veen RM
    J Orthop Surg Res; 2015 Sep; 10():145. PubMed ID: 26384316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2017; 106(6):326-327. PubMed ID: 28300001
    [No Abstract]   [Full Text] [Related]  

  • 38. Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.
    Dunn CJ; Goa KL
    Pharmacoeconomics; 1996 Aug; 10(2):179-90. PubMed ID: 10163420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
    Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ
    Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
    Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
    Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.